Antiretroviral regimens for preventing HIV infection in infants

Ekpini, René E.; Gilks, Charles
May 2007
Bulletin of the World Health Organization;May2007, Vol. 85 Issue 5, p483
Academic Journal
The article comments on the provision of antiretroviral (ARV) drugs to mothers and infants for the prevention of mother-to-child transmission (PMTCT) of human immunodeficiency virus (HIV) infection. It says that PMTCT initiatives are the key points to HIV-related care and treatment for women and children infected with HIV. It further says that the implementation of these initiatives should be taken as a chance to upgrade quality and increase uptake of maternal and child health services.


Related Articles

  • Vaginal gel may help prevent HIV.  // Contemporary Sexuality;Sep2010, Vol. 44 Issue 9, p6 

    This article reports on a study of vaginal gels that contain the antiretroviral drug tenofovir and whether they can help prevent human immunodeficiency virus (HIV).

  • Studies confirm ART prevented HIV in uninfected heterosexual partners. Henry, Jennifer // Infectious Disease News;Aug2011, Vol. 24 Issue 8, p1 

    The article discusses two clinical trials which concluded that once-daily antiretroviral therapy may reduce the risk for HIV infection among uninfected men and women who were exposed to HIV through heterosexual sex with an infected partner.

  • Preexposure Prophylaxis for HIV. Liu, Albert Y.; Grant, Robert M.; Buchbinder, Susan P. // JAMA: Journal of the American Medical Association;8/16/2006, Vol. 296 Issue 7, p863 

    The article discusses the potential efficacy of preexposure prophylaxis (PrEP) for the prevention of HIV infections. The daily and yearly incidence of new HIV infections is estimated. PrEP is contrasted with postexposure prophylaxis (PEP). A review of research on the efficacy of PrEP is...

  • Success with antiretroviral treatment for children in Kigali, Rwanda: Experience with health center/nurse-based care. Van Griensven, Johan; De Naeyer, Ludwig; Uwera, Jeanine; Asiimwe, Anita; Gazille, Claire; Reid, Tony // BMC Pediatrics;2008, Vol. 8, Special section p1 

    Background: Although a number of studies have shown good results in treating children with antiretroviral drugs (ARVs) in hospital settings, there is limited published information on results in pediatric programs that are nurse-centered and based in health centers, in particular on the...

  • The Cost-effectiveness of Human Immunodeficiency Virus (HIV) Preexposure Prophylaxis and HIV Testing Strategies in High-risk Groups in India. Kazemian, Pooyan; Costantini, Sydney; Kumarasamy, Nagalingeswaran; Paltiel, A David; Mayer, Kenneth H; Chandhiok, Nomita; Walensky, Rochelle P; Freedberg, Kenneth A // Clinical Infectious Diseases;2/15/2020, Vol. 70 Issue 4, p633 

    Background The human immunodeficiency virus (HIV) epidemic in India is concentrated among 3.1 million men who have sex with men (MSM) and 1.1 million people who inject drugs (PWID), with a mean incidence of 0.9–1.4 per 100 person-years. We examined the cost-effectiveness of both...

  • Romania's children with HIV--from tragedy to hope.  // Report on the Global HIV/AIDS Epidemic: UNAIDS - 2004;1/1/2004, p117 

    The article reports on the commitment of Romanian government to improve access to the treatment of children infected with HIV. It was reported that they are one of the first countries in Europe that introduced antiretroviral treatment. They have also passed a law in which guaranteeing HIV...

  • Resource allocation within the National AIDS Control Program of Pakistan: a qualitative assessment of decision maker's opinions. Sara Husain; Masood Kadir; Zafar Fatmi // BMC Health Services Research;2007, Vol. 7, p11 

    Background: Limited resources, whether public or private, demand prioritisation among competing needs to maximise productivity. With a substantial increase in the number of reported HIV cases, little work has been done to understand how resources have been distributed and what factors may have...

  • Maintaining cost-effective access to antiretroviral drug therapy through a collaborative approach to drug procurement, consensus treatment guidelines and regular audit: the experience of London HIV commissioners and providers. Foreman, Claire; Gazzard, Brian; Johnson, Margaret; Sharott, Peter; Collins, Simon // Sexually Transmitted Infections;Mar2012, Vol. 88 Issue 2, p112 

    Background In the UK, meeting the £20 billion efficiency challenge in the NHS requires new approaches to protect quality and improve productivity. In London, clinicians, people living with HIV and commissioners are collaborating to reduce the cost of antiretrovirals as part of the Quality...

  • Uptake of prevention of mother-to-child-transmission using Option B+ in northern rural Malawi: a retrospective cohort study. Price, Alison J.; Kayange, Michael; Zaba, Basia; Chimbwandira, Frank M.; Jahn, Andreas; Chirwa, Zengani; Dasgupta, Aisha N. Z.; Katundu, Cynthia; Saul, Jacqueline L.; Glynn, Judith R.; Koole, Olivier; Crampin, Amelia C. // Sexually Transmitted Infections;Jun2014, Vol. 90 Issue 4, p309 

    To identify points of dropout on the pathway from offering HIV testing to maintenance on antiretroviral therapy (ART), following the introduction of the Option B+ policy for pregnant women in Malawi (lifelong ART for HIV-positive mothers and 6 weeks nevirapine for the infants), a retrospective...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics